Looks like you clickedhttps://www.businesswire.com/news/home/20221117005394/en/BeiGene-Receives-European-Commission-Approval-for-BRUKINSA%C2%AE-zanubrutinib-for-the-Treatment-of-Adults-with-Chronic-Lymphocytic-Leukemia-CLL
If you do not want to visit that page, you can close this browser tab.
